MicroRNA 6825 (MIR6825)

MicroRNA 6825 (MIR6825) is a human microRNA gene classified as a non-coding RNA, implicated in the fine-tuning of gene expression by post-transcriptional mechanisms[1]. MicroRNAs are small (~20-24 nucleotide) molecules processed through sequential cleavage by RNase III enzymes Drosha (nuclear) and Dicer (cytoplasmic)[1][3][4]. The mature miRNA is loaded into the RNA-induced silencing complex (RISC), which guides the miRNA to target mRNAs, where it typically induces translational repression or contributes to mRNA degradation[1][3][4]. Like other miRNAs, MIR6825 is predicted to modulate the expression of multiple target genes simultaneously; however, there are currently no published data detailing its specific biological roles, explicit gene targets, disease relevance, or use as a drug target or biomarker[1]. This distinguishes it from well-characterized miRNAs such as miR-21 or let-7, which have defined roles in cancer, cell cycle, and more[2][4]. No drugs, diagnostic markers, or safety concerns are reported for MIR6825, and its molecular profile places it within the generic family of regulatory non-coding RNAs (miRNA class)[1][3][4]. Summary Interpretation: - MIR6825 is a valid, registered miRNA gene but currently lacks evidence to support its consideration as a specific therapeutic target, disease marker, or actionable biomolecule. - All provided names are correct, but no specific functions, disease associations, or drug interactions are substantiated in the literature as of now.

Other names

hsa-mir-6825microRNA mir-6825MIR6825MIR6825 RNA